Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-015784-13Phase 4Terminated
Phase 4 trial of Bronchitol and sodium chloride in subarachnoid hemorrhage (SAH), sponsored by Teemu Luostarinen. Primary endpoints: Hemodynamic effects, Acid-base balance and 1 more. Started Feb 2011; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-015784-13.